Delivery Order SPE2DB24D8003-SPE2DB24FJTQB

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The $2,781.06 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a range of pharmaceutical and medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of ANORO ELLIPTA 62.5-25 MCG INH 60S. The contract has a firm fixed price of $7,096.57 and a period of performance through March 10, 2025. This award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a broad range of pharmaceutical products,...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7E0S, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,936.74 firm fixed-price delivery order is for the procurement of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The contract has an ultimate completion date of June 5, 2024 and was awarded on June 4, 2024. It is not set aside for any specific business...
This federal contract award, valued at $1,371.74, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, and has an ultimate completion date of December 31, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. government, particularly the Department of Defense. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,201.77 firm fixed-price delivery order is for the medication Brovana (15 mcg/2 ml solution), which is used to treat respiratory conditions such as COPD. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The contract, valued at $7,225.70, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM inhalers. The award is associated with a larger Indefinite Delivery Contract (IDC) between Dakota...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2TQ5, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,122.22 firm fixed-price delivery order is for the procurement of 4562704947 INCRUSE ELLIPTA 62.5 MCG INH 30S, a pharmaceutical product. This award is not associated with a set-aside program and has a period of performance through November 6, 2023. Dakota Drug, Inc....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $5,203.05, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM, a medication used to treat asthma and COPD. The award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,379.65 firm-fixed-price delivery order is for the provision of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $15,235.54, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a firm fixed-price delivery order for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical program, which procures commercial medical equipment, accessories, consumables, and simulation equipment. The company holds a significant Indefinite...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB24FJTQB
    Delivery Order

This federal contract award, valued at $1,117.14, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract is for the delivery of ANORO ELLIPTA 62.5-25 MCG inhalers, which are used to treat respiratory conditions such as asthma and COPD.

This award is structured as a firm fixed-price delivery order and does not have a set-aside designation. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical, providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows it to deliver a comprehensive range of medical items through the DLA's ECAT Generation V Program.

Generated 12/19/24, 9:33 AM